Intrinsiqq
Calidi Biotherapeutics Inc. logo

Calidi Biotherapeutics Inc. Financials

CLDI

Compare

All currency values in $ millions unless otherwise noted

Scroll

Income Statement
DEC 2025
~6.4:1 split
DEC 2024
~4.7:1 split
DEC 2023
2:1 split
DEC 2022
DEC 2021
Revenues
Revenue–––$0–
General & Administrative$11$13$16$16–
Research & Development$10$9$13$7–
Total Operating Expenses$20$22$29$23–
Operating Income-$20-$22-$29-$23–
Non-Operating
Net Interest Expense-$0-$1-$1-$0–
Other Non-Operating Income (Expense)$0$0$1-$2–
EBT (Earnings Before Tax)-$20-$22-$29-$25–
Income Tax Expense$0$0$0$0–
Minority Interest-$0-$0–––
Net Income
Net Income-$20-$22-$29-$25–
Per Share Data
Revenue Per Share–––$9.52–
EPS (Basic)-$89.25-$535.50-$3,119.40$5,382.00–
EPS (Diluted)-$89.25-$535.50-$3,119.40$5,382.00–
Weighted Avg Shares (Basic)4,3028.0M16.9M8.5M–
Weighted Avg Shares (Diluted)4,3028.0M16.9M8.5M–
Shares Outstanding286,80044,472.2229,381.6674,72512,777.778

Calidi Biotherapeutics (CLDI) financials: revenue, profit and margins

Calidi Biotherapeutics (CLDI) generated about n/a in revenue and -$16 million in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Calidi Biotherapeutics profitable?+

Calidi Biotherapeutics reported about -$16 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 11 Nov 2026, covering the period ending 30 Sept 2026, as reported to the SEC. Data last refreshed 13 Nov 2026. How this is calculated.

Fiscal year ends Dec.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with CLDI

CompareIntrinsic value
INMBInmune Bio Inc.
$0.83-7.49%10
BCDABioCardia, Inc.
$0.79+2.60%26
ENZNViskase Holdings, Inc.
$4.35-1.14%0
SNTISenti Biosciences Inc.
$2.79-2.82%0
ALLOAllogene Therapeutics Inc.
$0.63-6.31%10
EXOZExozymes Inc.
$2.91-14.05%10
AIMAIM ImmunoTech Inc.
$0.11-4.50%25
CADLCandel Therapeutics Inc.
$5.04-1.75%10

Spot a number that looks wrong? Check it in CLDI's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing CLDI

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.